Psychoneuroendocrinology
Volume 34, Issue 9 , Pages 1338-1345 , October 2009

Pituitary response to metyrapone in Gulf War veterans: Relationship to deployment, PTSD and unexplained health symptoms

  • Julia A. Golier

      Affiliations

    • Departments of Psychiatry, James J. Peters VA Medical Center, Bronx, NY, United States
    • Mount Sinai School of Medicine, New York, NY, United States
    • Corresponding Author InformationCorresponding author at: James J. Peters VA Medical Center, OOMH, 130 West Kingsbridge Road, Bronx, NY 10468, United States. Tel.: +1 718 584 9000x5196; fax: +1 718 741 4775.
    • ,
  • James Schmeidler

      Affiliations

    • Mount Sinai School of Medicine, New York, NY, United States
    • ,
  • Rachel Yehuda

      Affiliations

    • Departments of Psychiatry, James J. Peters VA Medical Center, Bronx, NY, United States
    • Mount Sinai School of Medicine, New York, NY, United States

Received 14 July 2008 ,Revised 30 January 2009 ,Accepted 7 April 2009.

References 

  1. Abdel-Rahman A, Shetty AK, Abou-Donia MB. Disruption of the blood-brain barrier and neuronal cell death in cingulate cortex, dentate gyrus, thalamus, and hypothalamus in a rat model of Gulf-War syndrome. Neurobiol. Dis. 2002;10(3):306–326
  2. Aguilera G. Regulation of pituitary ACTH secretion during chronic stress. Front Neuroendocrinol. 1994;15(December (4)):321–350
  3. Baker DG, Ekhator NN, Kasckow JW, Dashevsky B, Horn PS, Bednarik L, et al. Higher levels of basal serial CSF cortisol in combat veterans with posttraumatic stress disorder. Am. J. Psychiatry. 2005;162(5):992–994
  4. Baker DG, Mendenhall CL, Simbartl LA, Magan LK, Steinberg JL. Relationship between posttraumatic stress disorder and self-reported physical symptoms in Persian Gulf War veterans. Arch. Intern. Med. 1997;157(18):2076–2078
  5. Barrett DH, Doebbeling CC, Schwartz DA, Voelker MD, Falter KH, Woolson RF, et al. Posttraumatic stress disorder and self-reported physical health status among U.S. Military personnel serving during the Gulf War period: a population-based study. Psychosomatics. 2002;43:195–205
  6. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, et al. The development of a Clinician-Administered PTSD Scale. J. Trauma Stress. 1995;8:75–90
  7. Borrelli E, Nestler EJ, Allis CD, Sassone-Corsi P. Decoding the epigenetic language of neuronal plasticity. Neuron. 2008;60(December (6)):961–974
  8. Bremner JD, Licinio J, Darnell A, Krystal JH, Owens MJ, Southwick SM, et al. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am. J. Psychiatry. 1997;154(5):624–629
  9. David AS, Farrin L, Hull L, Unwin C, Wessely S, Wykes T. Cognitive functioning and disturbances of mood in UK veterans of the Persian Gulf War: a comparative study. Psychol. Med. 2002;32(8):1357–1370
  10. Davis SD, Kator SF, Wonnett JA, Pappas BL, Sall JL. Neurally mediated hypotension in fatigued Gulf War veterans: a preliminary report. Am. J. Med. Sci. 2000;319(2):89–95
  11. de Kloet ER, Joëls M, Holsboer F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 2005;6(June (6)):463–475
  12. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis 1 Disorders (SCID). New York State Psychiatric Institute, Biometrics Research; 1995;
  13. Ford JD, Campbell KA, Storzbach D, Binder LM, Anger WK, Rohlman DS. Posttraumatic stress symptomatology is associated with unexplained illness attributed to Persian Gulf War military service. Psychosom. Med. 2001;63:842–849
  14. Fukuda K, Nisenbaum R, Stewart G, Thompson WW, Robin L, Washko RM, et al. Chronic multisymptom illness affecting Air Force veterans of the Gulf War. JAMA. 1998;280:981–988
  15. Golier JA, Legge J, Yehuda R. The ACTH response to dexamethasone in Persian Gulf War veterans. Ann. N.Y. Acad. Sci. 2006;1071:448–453
  16. Golier JA, Schmeidler J, Legge J, Yehuda R. Enhanced cortisol suppression to dexamethasone associated with Gulf War deployment. Psychoneuroendocrinology. 2006;31(10):1181–1189
  17. Golier JA, Schmeidler J, Legge J, Yehuda R. Twenty-four hour plasma cortisol and adrenocorticotropic hormone in Gulf War veterans: relationships to posttraumatic stress disorder and health symptoms. Biol. Psychiatry. 2007;62(10):1175–1178
  18. Golomb, B.A., 2003. A Review of the Scientific Literature as it pertains to Gulf War illnesses, vol. 2, Pyridostigmine Bromide. Rand Corporation.
  19. Haley RW, Fleckenstein JL, Marshall WW, McDonald GG, Kramer GL, Petty F. Effect of basal ganglia injury on central dopamine activity in Gulf War syndrome: correlation of proton magnetic resonance spectroscopy and plasma homovanillic acid levels. Arch. Neurol. 2000;57(9):1280–1285
  20. Haley RW, Kurt TL. Self-reported exposure to neurotoxic chemical combinations in the Gulf War. A cross-sectional epidemiologic study. JAMA. 1997;15:277(3):231–237
  21. Haley RW, Vongpatanasin W, Wolfe GI, Bryan WW, Armitage R, Hoffmann RF, et al. Blunted circadian variation in autonomic regulation of sinus node function in veterans with Gulf War syndrome. Am. J. Med. 2004;117(7):469–478
  22. Jacobson L. Hypothalamic–pituitary–adrenocortical axis regulation. Endocrinol. Metab. Clin. North Am. 2005;34(June (2)):271–292, vii
  23. Kanter ED, Wilkinson CW, Radant AD, Petrie EC, Dobie DJ, McFall ME, et al. Glucocorticoid feedback sensitivity and adrenocortical responsiveness in posttraumatic stress disorder. Biol. Psychiatry. 2001;50(4):238–245
  24. Kellner M, Wiedemann K, Yassouridis A, Levengood R, Guo LS, Holsboer F, et al. Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder. Biol. Psychiatry. 2000;47(2):107–111
  25. Kaufman J, Birmaher B, Perel J, Dahl RE, Moreci P, Nelson B, et al. The corticotropin-releasing hormone challenge in depressed abused, depressed nonabused, and normal control children. Biol. Psychiatry. 1997;42(October (8)):669–679
  26. Kellner M, Baker DG, Yehuda R. Salivary cortisol in Operation Desert Storm returnees. Biol. Psychiatry. 1997;42(9):849–850
  27. Lange G, Tiersky LA, Scharer JB, Policastro T, Fiedler N, Morgan TE, et al. Cognitive functioning in Gulf War illness. J. Clin. Exp. Neuropsychol. 2001;23(April (2)):240–249
  28. McCauley LA, Joos SK, Spencer PS, Lasarev M, Shuell T. Strategies to assess validity of self-reported exposures during the Persian Gulf War. Portland Environmental Hazards Research Center. Environ. Res. 1999;81(3):195–205
  29. Menon PM, Nasrallah HA, Reeves RR, Ali JA. Hippocampal dysfunction in Gulf War Syndrome. A proton MR spectroscopy study. Brain Res. 2004;1009(1–2):189–194
  30. Neylan TC, Lenoci M, Maglione ML, Rosenlicht NZ, Metzler TJ, Otte C, et al. Delta sleep response to metyrapone in post-traumatic stress disorder. Neuropsychopharmacology. 2003;28(September (9)):1666–1676
  31. Otte C, Lenoci M, Metzler T, Yehuda R, Marmar CR, Neylan TC. Effects of metyrapone on hypothalamic–pituitary-adrenal axis and sleep in women with post-traumatic stress disorder. Biol. Psychiatry. 2007;15;61(8):952–956
  32. Peckerman A, LaManca JJ, Smith SL, Taylor A, Tiersky L, Pollet C, et al. Cardiovascular stress responses andtheir relation to symptoms in Gulf War veterans with fatiguing illness. Psychosom Med. 2000;62(4):509–516
  33. Proctor SP, Heerlen T, White RF, Wolfe J, Burgos MS, Davis JD, et al. Health status of Persian Gulf War veterans: self-reported symptoms, environmental exposures and the effect of stress. Int. J. Epidemiol. 1998;27(6):1000–1010
  34. Rosenheck R. Overview of findings. In:  Rosenheck R,  Becknell H,  Blank AS,  Farley F,  Fontana A,  Friedman MJ,  Fulton J,  Kalsomine J,  Irishman M,  Gusman F,  Keane T,  Lehmann L,  Podium TB,  Ursine RJ,  Wolfe J editor. Returning Persian Gulf troops: First Year Findings. West Haven, CT: VA Medical Center; 1992;p. 1–19
  35. Schöneshöfer M, Schefzig B, Arabin S. Short-term kinetics of serum adrenal steroids and plasma ACTH after a single dose of metyrapone in man. J. Endocrinol. Invest. 1980;3(July–September (3)):229–236
  36. Skowera A, Hotopf M, Zwickau E, Varela-Calvino R, Unwin C, Nikolaou V, et al. Cellular immune activation in Gulf War veterans. J. Clin. Immunol. 2004;24(1):66–73
  37. Smith MA, Davidson J, Ritchie JC, Kudler H, Lipper S, Chappell P, et al. The corticotropin-releasing hormone test in patients with posttraumatic stress disorder. Biol. Psychiatry. 1989;26(August (4)):349–355
  38. Ströhle A, Holsboer F. Stress responsive neurohormones in depression and anxiety. Pharmacopsychiatry. 2003;36(November (Suppl. 3)):S207–S214
  39. Southwick SM, Morgan CA, Nicolaou AL, Charney DS. Consistency of memory for combat-related traumatic events in veterans of Operation Desert Storm. Am. J. Psychiatry. 1997;154(2):173–177
  40. Steele L. Prevalence and patterns of Gulf War illness in Kansas veterans: association of symptoms with characteristics of person, place, and time of military service. Am. J. Epidemiol. 2000;152(10):992–1002
  41. Stein PK, Domitrovich PP, Ambrose K, Lyden A, Fine M, Gracely RH, et al. Sex effects on heart rate variability in fibromyalgia and Gulf War illness. Arthritis Rheum. 2004;51(5):700–708
  42. Stretch RH, Bliese PD, Marlowe DH, Wright KM, Knudson KH, Hoover CH. Physical health symptomatology of Gulf War-era service personnel from the states of Pennsylvania and Hawaii. Mil. Med. 1995;160(3):131–136
  43. The Iowa Persian Gulf Study Group . Self-reported illness and health status among Gulf War veterans. A population-based study. JAMA. 1997;1997(3):238–245
  44. Unwin C, Blatchley N, Coker W, Ferry S, Hotopf M, Hull L, et al. Health of UK servicemen who served in Persian Gulf War. Lancet. 1999;353(9148):169–178
  45. Wolfe J, Proctor SP, Erickson DJ, Heeren T, Friedman MJ, Huang MT, et al. Relationship of psychiatric status to Gulf War veterans’ health problems. Psychosom. Med. 1999;61(4):532–540
  46. Weaver IC. Epigenetic programming by maternal behavior and pharmacological intervention. Nature versus nurture: let's call the whole thing off. Epigenetics. 2007;2(January–March (1)):22–28
  47. Wolfe J, Proctor SP, Erickson DJ, Hu H. Risk factors for multisymptom illness in US Army veterans of the Gulf War. J. Occup. Environ. Med. 2002;44(3):271–281
  48. Yehuda R, Levengood RA, Schmeidler J, Wilson S, Guo LS, Gerber D. Increased pituitary activation following metyrapone administration in post-traumatic stress disorder. Psychoneuroendocrinology. 1996;21(1):1–16
  49. Yehuda R, Bierer LM. Transgenerational transmission of cortisol and PTSD risk. Prog. Brain Res. 2008;167:121–135
  50. Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H. Normal pituitary response to metyrapone in the morning in depressed patients: implications for circadian regulation of corticotropin-releasing hormone secretion. Biol. Psychiatry. 1997;15;41(12):1149–1155
  51. Zhang Q, Zhou XD, Denny T, Ottenweller JE, Lange G, LaManca JJ, et al. Changes in immune parameters seen in Gulf War veterans but not in civilians with chronic fatigue syndrome. Clin. Diagn. Lab. Immunol. 1999;6(1):6–13

PII: S0306-4530(09)00119-X

doi: 10.1016/j.psyneuen.2009.04.004

Psychoneuroendocrinology
Volume 34, Issue 9 , Pages 1338-1345 , October 2009

Article Tools

* Image Usage & Resolution